HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seage, G R Articles by Epstein, A M Search for Related Content PubMed PubMed Citation Articles by Seage, G R, 3rd Articles by Epstein, A M

Effect of changing patterns of care and duration of survival on the cost of treating the acquired immunodeficiency syndrome (AIDS).

G R Seage, 3rd, S Landers, G A Lamb and A M Epstein

Division of Public Health, Boston Department of Health and Hospital, MA 02118.

We performed a two-year cost of illness study of 240 AIDS patients (55 percent of all Massachusetts cases) diagnosed and treated at five hospitals from March 1984 through February 1986. Sociodemographic and clinical data as well as information on medical utilization were obtained from review of inpatient and outpatient hospital records. The yearly inpatient cost per patient decreased by 28 percent from $38,369 in year one to $27,714 in year two. These changes were related to shorter lengths of stay (from 20.6 days to 16.8 days per hospitalization, mean difference of 3.8 days, 95% CI of the difference -.2, 7.8), and less costly hospitalizations (from $12,463 to $9,957, mean difference of $2,506, 95% CI of the difference $135, $4,877). The probability of hospitalization, however, was similar in both years. These patterns of care were still evident after controlling for transmission category, race, site, mortality, insurance, age, gender, number and type of opportunistic diseases and time since diagnosis. Although the cost per patient per year decreased between years one and two, median survival increased by 70 percent (from 10 to 17 months). Hence overall estimated lifetime costs increased by 24 percent.

This article has been cited by other articles:

				C. L. BEAUDIN and S. M. CHAMBRE HIV/AIDS as a Chronic Disease: Emergence From the Plague Model American Behavioral Scientist, May 1, 1996; 39(6): 684 - 706. [Abstract]

				T. Hammett, D. Hunt, M. Gross, W. Rhodes, and S. Moini Stemming the Spread of HIV among IV Drug Users, their Sexual Partners, and Children: Issues and Opportunities for Criminal Justice Agencies Crime Delinquency, January 1, 1991; 37(1): 101 - 124. [Abstract]